Fertility Preserving Surgery Outcomes for Ovarian Malignancy: Data from a Tertiary Cancer Centre in Central London
Open Access
- 3 June 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3195
Abstract
Fertility Sparing Surgery (FSS) appears to be a safe means of treating early-stage ovarian cancer based on relatively limited evidence. However, there is currently insufficient evidence to aid women in counselling about their potential fertility outcomes. The aim of this study was to assess the reproductive outcomes and prognosis of women who have undergone FSS for ovarian malignancy. Between 1 June 2008 and 1 June 2018, a retrospective review of a clinical database was conducted to identify all consecutive patients who underwent FSS in a central London gynaecological oncology centre. All patients with a histological diagnosis of ovarian malignancy (excluding borderline ovarian tumours) were eligible. All identified patients were then prospectively called into a follow up and asked to complete a questionnaire about their fertility outcomes. A total of 47 women underwent FSS; 36 were included in this study. The mean age was 30.3 years (95% Confidence Interval [CI]: 27.6 to 33.0 years). During the study period, 17/36 (47.2%) of the women had attempted to conceive following surgery, with a successful live birth rate of 52.9% (9/17). The mean time of recurrence was 125.3 months (95% CI: 106.5–144.1 months). The mean time to death was 139.5 months (95% CI: 124.3–154.8). The cancer grade, tumour stage and use of Assisted Reproductive Technology (ART) were the main factors significantly associated with the risk of recurrence and death. In conclusion, this study suggests that a large proportion of women will not attempt to conceive following FSS. For those who do attempt to conceive, the likelihood of achieving a live birth is high. However, careful counselling about the higher risk of recurrence and worse survival for women with high grade cancer, disease Stage > IA and potentially those who undergo ART is essential before contemplating FFS.Keywords
This publication has 23 references indexed in Scilit:
- Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancerOncotarget, 2016
- Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issuesAnnals of Oncology, 2016
- Fertility preservation in women with cervical, endometrial or ovarian cancersGynecologic Oncology Research and Practice, 2016
- Diagnosis, Treatment, and Follow-Up of Borderline Ovarian TumorsThe Oncologist, 2012
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigmGynecologic Oncology, 2009
- Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancerInternational Journal of Cancer, 2008
- [WHO histological classification of ovarian tumors. Geneva, 1999 (R.E.Scully, L.H.Sobin].2005
- Histological classification of ovarian cancerMedical Molecular Morphology, 2003
- Long-Term Survival and Patterns of Care in Women with Ovarian Tumors of Low Malignant PotentialGynecologic Oncology, 2002
- Having children after cancerCancer, 1999